"The layoffs are part of a transformation plan approved by Takeda's board on March 25, expected to generate more than 200 billion Japanese yen in annualized savings by fiscal 2028, or about $1.25 billion."
"CEO-elect Julie Kim stated, 'Today, Takeda is setting the stage to make a greater impact on the lives of patients as we prepare to launch multiple new medicines and continue to deliver on the promise of our pipeline.'"
"The latest layoffs continue a series of pullbacks by the biopharma giant, which has its U.S. base in Massachusetts, including previous job cuts and restructuring efforts."
Takeda is implementing layoffs affecting nearly 250 employees at its Kendall Square location in Cambridge. This is part of a broader restructuring plan aimed at saving $1.25 billion annually by 2028. The layoffs will begin in July and may extend into 2026 and 2027. The plan, approved by Takeda's board, aims to simplify operations and prepare for upcoming product launches. CEO-elect Julie Kim emphasized the need for deliberate steps to enhance patient impact and long-term growth. Takeda has also been reducing its physical footprint in Cambridge.
Read at Boston.com
Unable to calculate read time
Collection
[
|
...
]